Phase I study of palifosfamide in combination with standard care in patients with small cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 05 May 2011
At a glance
- Drugs Palifosfamide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 05 May 2011 Status changed from planning to recruiting.
- 29 Sep 2010 New trial record